Literature DB >> 17919640

[Measuring quality of life in end-stage renal disease. Transcultural adaptation and validation of the specific Kidney Disease Quality of Life questionnaire].

Stéphanie Boini1, Alain Leplege, Carole Loos Ayav, Patrick Français, Emmanuel Ecosse, Serge Briançon.   

Abstract

End-stage renal disease has an important impact on the patients' daily life, which can be measured by quality of life questionnaires. The objective of this work was to adapt the Kidney Disease Quality of Life questionnaire (KDQoL) into French and to determine its basic psychometric properties, i.e. validity and reliability. The KDQoL consisted of 8 generic dimensions and 11 specific dimensions. The questionnaire was translated several times independently, and then submitted to a committee of professionals. The study of the measurement properties was carried out near 68 dialysis patients. KDQoL is valid and reproducible, and has properties comparable to the original instrument: missing items proportion of 5.5%, limited floor and ceiling effects (except for 4 dimensions), Cronbach alpha coefficient varying from 0.64 to 0.92 (except for 2 dimensions), test-retest coefficient greater than 0.67 (except for 3 dimensions), and the items of KDQoL were better correlated with their dimension than with other dimensions (except for 2 dimensions). Correlations between the generic and the specific scores showed the absence of redundancies between specific and generic dimensions. Thus the French version has comparable properties to the original KDQoL. This questionnaire can be used to measure the quality of life of the dialysis patients. It constitutes a good tool in clinical research, allowing international comparisons.

Entities:  

Mesh:

Year:  2007        PMID: 17919640     DOI: 10.1016/j.nephro.2007.05.005

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  6 in total

1.  Changes in health-related quality of life in patients of self-care vs. in-center dialysis during the first year.

Authors:  Carole Loos-Ayav; Luc Frimat; Michèle Kessler; Jacques Chanliau; Pierre-Yves Durand; Serge Briançon
Journal:  Qual Life Res       Date:  2007-11-28       Impact factor: 4.147

2.  Predialysis therapeutic care and health-related quality of life at dialysis onset (The pharmacoepidemiologic AVENIR study).

Authors:  Stephanie Boini; Luc Frimat; Michele Kessler; Serge Briançon; Nathalie Thilly
Journal:  Health Qual Life Outcomes       Date:  2011-01-24       Impact factor: 3.186

Review 3.  Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review.

Authors:  Olalekan Lee Aiyegbusi; Derek Kyte; Paul Cockwell; Tom Marshall; Adrian Gheorghe; Thomas Keeley; Anita Slade; Melanie Calvert
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

4.  Impact of superimposed nephrological care to guidelines-directed management by primary care physicians of patients with stable chronic kidney disease: a randomized controlled trial.

Authors:  Patrick Saudan; Belen Ponte; Nicola Marangon; Chantal Martinez; Lena Berchtold; David Jaques; Thomas Ernandez; Sophie de Seigneux; Sebastian Carballo; Thomas Perneger; Pierre-Yves Martin
Journal:  BMC Nephrol       Date:  2020-04-09       Impact factor: 2.388

5.  Comparison of physical activity and quality of life in home haemodialysis (HHD) patients versus conventional in-centre haemodialysis (ICHD) patients: the observational, longitudinal, prospective, international, multicentric SeCoIA study protocol.

Authors:  Natalia Target; Cécile Courivaud; Pierre Antoine Michel; Salima Daoud; Michel Thomas
Journal:  BMC Nephrol       Date:  2020-11-23       Impact factor: 2.388

6.  The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study.

Authors:  Bénédicte Stengel; Christian Combe; Christian Jacquelinet; Serge Briançon; Denis Fouque; Maurice Laville; Luc Frimat; Christophe Pascal; Yves-Edouard Herpe; Jean-François Deleuze; Joost Schanstra; Ron L Pisoni; Bruce M Robinson; Ziad A Massy
Journal:  Nephrol Dial Transplant       Date:  2013-09-24       Impact factor: 5.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.